

Environmental pollution must become a central focus of the global fight against antimicrobial resistance (AMR), with experts warning that failure to address contamination from pharmaceutical industries, agriculture, healthcare facilities and poor waste management could undermine efforts to tackle drug-resistant infections.
The United Nations Environment Programme (UNEP) says environmental pollution contributes to the emergence, transmission and spread of drug-resistant microorganisms, stressing that the environment cannot be separated from human, animal and plant health in the global response to AMR.
Speaking at the sixth Annual Global Media Forum on AMR, Aitziber Echeverria, AMR Coordinator at UNEP’s Chemicals and Health Branch, said the world must move beyond recognising the environmental dimensions of antimicrobial resistance to implementing practical solutions.
“The environment plays a key role in the emergence, transmission and spread of AMR. The environment and AMR cannot be treated separately. That is the One Health concept,” she said.
Echeverria identified pharmaceutical manufacturing, agriculture and food systems, healthcare facilities, and municipal waste and wastewater management as four priority sectors requiring urgent intervention.
She warned that reducing antimicrobial residues, resistant microorganisms and resistance genes released into the environment must become a priority.
“Environmental action on AMR is not an optional addition to the response. It is a prerequisite for success,” she stressed.
She called on governments to invest in wastewater treatment, safe disposal of antimicrobials, laboratory capacity and environmental surveillance, while ensuring that environmental authorities are represented in national AMR governance structures.
The warning comes as the World Health Organization (WHO) estimates that bacterial antimicrobial resistance was associated with more than 4.7 million deaths globally in 2021.
Director of WHO’s Department of Antimicrobial Resistance and Director of the Quadripartite Joint Secretariat on AMR, Dr Jean-Pierre Nyemazi, described the crisis as one of the world’s most urgent health and development challenges.
“AMR is one of the most urgent global health threats and development challenges. It threatens our ability to treat infections, protect animal and plant health, and produce safe food, and also has an impact on the environment,” he said.
Dr Nyemazi, who spoke ahead of the 2026 World AMR Awareness Week scheduled for November 18 to 24, said the misuse and overuse of antimicrobials, inadequate infection prevention, poor water and sanitation, and environmental contamination continue to drive the crisis.
He, however, expressed concern that global political commitments are yet to translate into sufficient action at the country level.
“The gap between commitments and pledges versus implementation remains wide,” he said, identifying limited financing, fragmented coordination and weak surveillance as major obstacles.
At the 2024 United Nations General Assembly High-Level Meeting on AMR, world leaders pledged to reduce deaths associated with bacterial antimicrobial resistance by 10 per cent by 2030, against a 2019 baseline of 4.95 million deaths.
Countries also committed to ensuring that at least 60 per cent have funded national AMR action plans by 2030.
Providing an update on implementation efforts, Dr Kefas Samson, Senior Technical Officer and Lead of Multisectoral Coordination in WHO’s AMR Department, identified inadequate financing, weak surveillance systems, limited diagnostic capacity, shortages of health workers and unequal access to quality-assured medicines as persistent challenges.
He described the updated Global Action Plan on AMR for 2026 to 2036 as a renewed framework for translating international commitments into measurable interventions.
“It is not just a plan; but a framework that translates the aspirations and ambitions of the political declaration on AMR 2024 into tangible actions at the country level,” he said.
The plan adopts a One Health approach, bringing together human health, animal health, agriculture and environmental sectors, with priorities including infection prevention, responsible antimicrobial use, stronger laboratories, research, innovation and sustainable financing.
Meanwhile, the Food and Agriculture Organization of the United Nations (FAO) has warned that global antibiotic use in livestock could increase by nearly 30 per cent by 2040 without urgent intervention.
FAO Deputy Chief Veterinarian and Chief of its One Health and Disease Control Branch, Dr Junxia Song, said improved animal health and better farm management practices could reduce antibiotic use in livestock by as much as 57 per cent.
“Prevention must become central to the global fight against antimicrobial resistance, with farmers placed at the heart of the response,” she said.
Song said FAO was addressing the challenge through its ten-year initiative, Reduce the Need for Antimicrobials on Farms (RENOFARM), which promotes better animal health services, improved farming practices, alternatives to antimicrobials, innovation and partnerships.
She disclosed that more than 400 partners, including over 80 FAO member countries, are already participating in the initiative.
Similarly, the World Organisation for Animal Health (WOAH) has called for increased investment in animal health systems, describing disease prevention as a critical strategy for reducing dependence on antibiotics.
WOAH Programme Officer, Dr Jane Lwoyero, said every dollar invested in preventing animal diseases and strengthening animal health systems could generate a return of 28 dollars.
“Stronger vaccination, farm biosecurity, surveillance and veterinary services are essential to preventing infections and reducing antimicrobial use,” she said.
She warned that animal diseases account for estimated annual global losses of up to 300 billion dollars, while fewer than 20 per cent of WOAH member countries vaccinate animals against notifiable diseases.
Chairperson of the Global AMR Media Alliance (GAMA) and host of the media forum, Shobha Shukla, also warned that seemingly minor injuries, including cuts and needle pricks, could expose people to drug-resistant infections that may be difficult or even impossible to treat.
She urged the public to protect the effectiveness of antibiotics, antifungals, antivirals and antiparasitic medicines by avoiding their misuse and overuse.
Shukla said the next phase of the global AMR response must focus on ensuring that countries have the funding, surveillance systems, laboratory capacity and accountability mechanisms needed to implement their national action plans.
The sixth Global Media Forum was organised ahead of World AMR Awareness Week, with the 2026 theme: “One Health, One Action: Prevent AMR Now.”
The discussions also come ahead of the Fifth Global High-Level Ministerial Conference on AMR, scheduled to hold in Abuja, Nigeria, from December 6 to 8, 2026.
The conference is expected to review global progress, address implementation challenges and renew political commitments towards tackling antimicrobial resistance.
As the global community prepares for the Abuja meeting, experts insist that commitments must translate into measurable results, warning that the fight against drug resistance cannot succeed without protecting human health, animals, food systems and the environment.
